Status:
NO_LONGER_AVAILABLE
CAP-1002 in Severe COVID-19 Disease
Lead Sponsor:
Capricor Inc.
Conditions:
COVID-19
Eligibility:
All Genders
18+ years
Brief Summary
This expanded access protocol will enroll subjects with a clinical diagnosis of COVID-19 confirmed by laboratory testing and who are in critical condition as indicated by life support measurements. El...
Detailed Description
This is an expanded access protocol that will enroll subjects with clinical diagnosis of COVID-19 infection confirmed by laboratory testing and who are in critical condition as indicated by life suppo...
Eligibility Criteria
Inclusion
- Inclusion Criteria:
- Male or female subjects at least 18 years of age at time of consent
- Confirmed COVID-19 infection by clinical diagnosis and laboratory testing
- In critical condition as indicated by life support measurements
- Have one or more of the following laboratory parameters:
- lymphocytopenia
- elevated IL-6
- elevated Troponin I/Troponin T (TnI/T)
- elevated myoglobin
- elevated C-Reactive Protein (CRP)
Exclusion
Key Trial Info
Start Date :
Trial Type :
EXPANDED_ACCESS
End Date :
Estimated Enrollment :
Patients enrolled
Trial Details
Trial ID
NCT04338347
Last Update
December 1 2020
Active Locations (1)
Enter a location and click search to find clinical trials sorted by distance.
1
Cedars-Sinai Medical Center
Los Angeles, California, United States, 90048